David E. I. Pyott
Director · Tarsus Pharmaceuticals, Inc.
- 2025
- Sep 17, 2026
- 8
Summary
Latest filing:
David E. I. Pyott is Director of Tarsus Pharmaceuticals, Inc. (TARS). 8 SEC Form 4 filings on record going back to 2025, most recently on 17 September 2026. Most recent open-market trade: sold $5K of ALNY on 3 June 2026. Lifetime open-market sales: $1.15M.
Recent transactions
10The latest 10 SEC Form 4 transactions reported by David E. I. Pyott.
Trading pattern
InsiderAlpha's records for David E. I. Pyott go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. 7 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David E. I. Pyott files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bobak R. Azamian - $4.69M in TARS purchases and sales in the last 12 months
- William J. Phd Link - $2.62M in TARS purchases and sales in the last 12 months
- Elizabeth Yeu Lin - $2.20M in TARS purchases and sales in the last 12 months
- Seshadri Neervannan - $2.00M in TARS purchases and sales in the last 12 months
- Jeffrey S. Farrow - $1.32M in TARS purchases and sales in the last 12 months
- Aziz Mottiwala - $893K in TARS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David E. I. Pyott?
David E. I. Pyott is a corporate insider, tracked as Director of Tarsus Pharmaceuticals, Inc. (TARS). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David E. I. Pyott submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David E. I. Pyott been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.15M) across all tracked filings.